News Column

SORRENTO THERAPEUTICS, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

June 23, 2014



Item 5.07 Submission of Matters to a Vote of Security Holders

On June 19, 2014, Sorrento Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). A total of 16,734,377 shares of common stock, constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting, as set forth in the Definitive Proxy Statement, filed with the SEC on April 29, 2014, are as follows:

Proposal 1. All of the seven (7) nominees for director were elected to serve until the 2015 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death. The result of the votes to elect the seven (7) directors was as follows:

Directors For Against Abstain Henry Ji, Ph.D. 9,905,779 0 4,877,565 William Marth 14,147,511 0 635,833 Vuong Trieu, Ph.D. 7,536,075 0 7,247,269 Kim D. Janda, Ph.D. 8,286,704 0 6,496,640 Cam Gallagher, MBA 11,973,541 0 2,809,803 Jaisim Shah 12,607,741 0 2,175,603 Mark Durand 14,147,511 0 635,833



Proposal 2. The appointment of Mayer Hoffman McCann P.C. as the Company's independent registered public accounting firm for its fiscal year ended December 31, 2014 was ratified and approved by the stockholders by the votes set forth in the table below:

For Against Abstain 16,326,533 326,814 81,030



Proposal 3. The amendment to the Company's 2009 Stock Incentive Plan (the "Plan") to (i) increase the number of shares authorized to be issued pursuant to the Plan from 1,560,000 to 3,760,000, and (ii) delete the Plan's evergreen provision:

For Against Abstain 10,924,630 3,814,871 43,843



Proposal 4. The compensation of the Company's named executive officers was approved, on an advisory basis, by the stockholders by the votes set forth in the table below:

For Against Abstain 12,586,500 2,142,737 54,107



Proposal 5. The recommendation of a one year frequency with which the Company should conduct future stockholder advisory votes on named executive officer compensation, was approved, on an advisory basis, by the stockholders by the votes set forth in the table below:

One Year Two Years Three Years 11,427,031 683,918 2,667,786



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters